Garry E. Menzel - 10 Jun 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Karin Yoo, Attorney-in-Fact
Issuer symbol
BDTX
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 19:04:22 UTC
Previous filing
08 Jun 2022
Next filing
26 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDTX Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 10 Jun 2022 Common Stock 15,000 $2.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 7, 2023 or (ii) the Issuer's next annual meeting of stockholders.